Skip to main content
. 2021 Sep 9;13(18):4533. doi: 10.3390/cancers13184533
BICR Blinded independent central review
CAD Computer-aided detection
CT Computed tomography
DOP Date of progression
KPI Key performance indicator
LMS Lesion management solution
NSCLC Non-small cell lung cancer
ORR Overall response rate
OS Overall survival
PD Progressive disease
PFS Progression-free survival
RECIST Response evaluation criteria in solid tumors
RTPR Radiologic time-point response
SCLC Small-cell lung cancer
SD Stable disease